Aurimic
Active substance
ATC code
Species
Dogs and cats
Indications
For the treatment of otitis externa and small localised superficial skin infections in dogs and cats caused by infections with the following miconazole and polymyxin B sensitive bacteria and fungi:
• Gram-positive bacteria
- Staphylococcus spp.
- Streptococcus spp.
• Gram-negative bacteria
- Pseudomonas spp.
- Escherichia coli
• Fungi
- Malassezia pachydermatis
- Candida spp.
- Microsporum spp.
- Trichophyton spp.
Treatment of Otodectes cynotis (ear mites) infestations where there is concurrent infection with miconazole and polymyxin B sensitive pathogens.
Dose to be administered and administration route
For auricular and cutaneous use.
Shake well before use. Any contamination of the dropper should be strictly avoided.
At the beginning of treatment, hair surrounding or covering the lesions must be clipped; this should be repeated during treatment if necessary.
Infections of the external auditory canal (otitis externa):
Clean the external ear canal and auricle and place 5 drops of the veterinary medicinal product into the external auditory canal twice a day. Massage the ear and the auditory canal thoroughly to ensure proper distribution of the active substances, but gently enough to avoid causing pain to the animal.
Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms, at least for 7 - 10 days up to 14 days. The success of the treatment should be verified by a veterinarian before discontinuing treatment.
Skin infections (small localised superficial):
Apply a few drops of the veterinary medicinal product to the skin lesions to be treated twice a day and rub well.
Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms, up to 14 days.
In some persistent cases (ear or skin infections), treatment may need to be continued for 2 to 3 weeks. In cases where prolonged treatment is necessary repeated clinical examinations including a re- assessment of the diagnosis are required.
Adverse reactions
Use of this veterinary medicinal product may very rarely be associated with the occurrence of deafness (especially in older dogs), in this case treatment should be discontinued.
Prolonged and extensive use of topical corticosteroid preparations is known to trigger local immunosuppression including increased risk of infections, thinning of the epidermis and delayed wound healing, telangiectasia and increased vulnerability of the skin to bleeding and systemic effects, including suppression of adrenal function.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
References
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 57446/4004 |
| EAN | 5055037401929 |
Similar products
Showing 1 of 1 results
